Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65 andro litigation

This article was originally published in The Tan Sheet

Executive Summary

California AG "has presented sufficient evidence to create a triable issue of material fact" on whether androstenedione fits within definition of "anabolic steroid," Oakland state court Judge Ronald Sabraw rules Nov. 5, denying supplement marketers' motion for summary judgment in Prop 65 case. Court says SB 1884, which was signed into law in September and requires special content and warning statements on supplements containing steroid hormone precursors, "does not compel the conclusion that andro cannot be an anabolic steroid" (1"The Tan Sheet" Oct. 7, 2002, p. 7). Trial in the case is scheduled for March...

You may also be interested in...



Calif. Ephedra Laws To Be Implemented With Help From NNFA

The National Nutritional Foods Association is working with the California Department of Health to help create standardized education programs for retail employees to enforce the state's new ephedra laws

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Global Pharma Guidance Tracker – March 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel